导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -13.54% | 884/1050 |
| 近一周 | -4.34% | 1014/1104 |
| 近一月 | -0.28% | 100/1102 |
| 近一季 | -7.62% | 557/1092 |
| 近半年 | -9.34% | 743/1070 |
| 近一年 | -17.19% | 845/1018 |
| 近两年 | 28.95% | 687/926 |
| 近三年 | 8.99% | 600/834 |
| 成立以来 | 6.41% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-11.81% 1029/1070 |
2.08% 658/1101 |
- - |
- - |
| 2025 | 28.68% 493/1065 |
7.40% 257/1014 |
9.06% 128/1038 |
17.52% 681/1050 |
-6.53% 774/1065 |
| 2024 | 12.86% 220/1011 |
-1.05% 369/960 |
8.30% 28/983 |
9.00% 712/991 |
-3.38% 562/1011 |
| 2023 | -20.00% 669/952 |
0.68% 596/880 |
-6.01% 576/895 |
-6.75% 409/915 |
-9.35% 831/952 |
| 2022 | -16.60% 212/867 |
-14.65% 241/773 |
12.08% 188/806 |
-19.96% 751/845 |
8.93% 100/867 |
| 2021 | -16.47% 523/740 |
0.86% 115/580 |
13.31% 279/659 |
-14.00% 588/704 |
-15.01% 682/740 |
| 2020 | - - |
- - |
- - |
-2.54% 442/517 |
15.41% 196/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 银华港股通精选股票发起式A VS. 东吴新产业精选股票A(580008) |